1973.9-1976.12 Bachelor of Chinese Medicine, Beijing College of Traditional Chinese Medicine.

1989.1-1991.6 Ph.D. candidate in School of Pharmacy, University of London, UK

1991.7-1993.6 postdoctoral fellow of GlaxoSmithKline, University of London, UK.

2. Overseas study and research experience:

1987.9-1988.4438+02 Visiting Scholar, School of Pharmacy, University of London, UK.

3. Work experience:

1977438+0 ——1984.12 Intern researcher, Institute of Pharmacology, China Academy of Medical Sciences.

1985438+0 ——1987.08 Assistant Research Fellow, Institute of Medicinal Plants, China Academy of Medical Sciences.

1987.09 ——1993.07 Ph.D. and postdoctoral fellow, School of Pharmacy, University of London, UK.

1993.11-1994.03 Associate Research Fellow, Institute of Medicinal Plants, China Academy of Medical Sciences.

1994.04 ——1994.07 Researcher, Institute of Medicinal Plants, China Academy of Medical Sciences.

1994.07 ——1995.08 deputy director, institute of medicinal plants, China academy of medical sciences.

1995.08 ——1996.05 Director of Yunnan Branch of Institute of Medicinal Plants, China Academy of Medical Sciences.

1996.05—2001.12 Director, Institute of Medicinal Plants, China Academy of Medical Sciences.

2002.01—2006.012 concurrently served as director of R&D of huiren group.

200 1. 12—2002.09 Researcher, Institute of Medicinal Plants, China Academy of Medical Sciences.

2002. 10 —— Director of National Engineering Research Center for Manufacturing Technology of Solid Preparations of Traditional Chinese Medicine.

Chief Professor, Jiangxi College of Traditional Chinese Medicine

2007. 1 1- Professor, School of Pharmacy, School of Medicine, Suzhou University.

2008. 11-201/0.5 Director, School of Medicine, Suzhou University (1) Research on New Traditional Chinese Medicine and Natural Medicine.

(2) Study on the effective components of traditional Chinese medicine and natural medicine.

(3) Study on quality control methods of traditional Chinese medicine.

(4) Study on the functional material basis and compatibility mechanism of traditional Chinese medicine compound. Professor Yang Shilin has been mainly engaged in the research of effective components of medicinal plants and the development of new drugs for many years. Using modern science, technology and methods, more than 2,000 compounds were isolated and identified from more than 90 commonly used medicinal plants, of which nearly 600 were new compounds, and more than 400 academic papers were published in influential academic journals at home and abroad. Among them, SCI has collected more than 100 articles, published 6 academic monographs100, made more than 70 academic reports at international and domestic professional academic conference forums, and trained more than 80 postdoctoral, doctoral and master students. In recent five years, Professor Yang Shilin has presided over 16 national-level projects, including the National 973 Plan, the National Twelfth Five-Year Plan, the National Eleventh Five-Year Plan, and major national special projects on new drug creation. Received more than 76 million yuan of national vertical research funds and more than 80,000 yuan of horizontal research funds/kloc-0, and won national and provincial scientific and technological progress awards for many achievements.

1, paper

1. Xu Qingmin, Zou, Xu Lizhong *, Yang Shilin. A new polyoxyethylene cyclohexene in Ziyupan, Guizhou Province and its antitumor activity. Bulletin of Chemical Pharmacy 2005,53 (7): 826-829.

2. Xu Qingmin, Zou, Xu Lizhong *, Yang Shilin. Two new polyoxyethylene cyclohexenes in Ziyupan, Guizhou. China Chemical Lite, 2005,16 (10):1343-1346.

3. Xu Qingmin, Liu, Zou, Yang Shilin * and Xu Lizhong. Two new polyoxyethylene cyclohexenes in Ziyupan, Guizhou. Product Research Report of Asian Countries, 2009, pp. 24-28.

4. Xu QM, Liu, Li Xuri, Feng, Yang. Two new phenylethylene glycol derivatives were isolated from Rhododendron odoratum. Mandshurica, Chemical Pharmaceutical Bulletin 2009,57 (8): 863-866.

5. Xu Qingmin, Li Qiang, Liu, Feng, Yang Shilin *, Li Xuri. New lignans in the incense of Calamagrostis amurensis. Datura. Chemistry of natural compounds, 20 10/0,46 (3): 366-369.

6. Xu QM, Liu, Li Xuri, Feng, Yang. C28 sterols with cyclopentane rings at positions C-22 and 26 are from Potentilla anserina (berries of Physalis alkekengi). J Research on Production in Asian Countries, 20 10, 12 (9): 752-759.

2. subjects

1. Study on the Development of Anti-tumor Effective Fractions of Lysimachia edulis (No.2009zx09102-135), 2.8 million yuan, hosted from June 2009 to March 201year.

2. Study on Anti-tumor Active Components of Lysimachia crispus (No.30873362), 300,000 yuan, June-February 20, 20091/,presided over.

3. National Natural Science Foundation of China (81kloc-0/72954) studies on the anti-tumor structure-activity relationship and mechanism of chemical components of polyoxosubstituted cyclohexenes in Corydalis, 600,000 yuan, 2012-20/5-12.

4. National Twelfth Five-Year Plan supported by science and technology, standardized planting and comprehensive development technology of Chinese herbal medicines in East China, 40 million yuan, 20121-201412, presided over.

5. Basic research on compatibility and toxicity characterization of the sub-project "Half Peel Attacking Wu" of the National 973 Program (No.201kloc-0/CB 505300), 940,000 yuan, 20 12+0-2065438.

6. Research on Key Technologies of Effective Components of Traditional Chinese Medicine, a sub-project of the National Eleventh Five-Year Plan, with RMB 654.38+00,000, 2065.438+02,654.38+0-2065.438+04,654.38+02, presided over.

3. Works

1, VCD disc of commonly used medicinal plants in China, 1998, published by Peking union medical college single image publishing house, editor in chief.

2. Concise Manual of Natural Active Ingredients, 1998, published by China Medical Science and Technology Press, deputy editor.

3. Modern Research and Clinic of TCM, 1997, published by TCM Ancient Books Publishing House, specially edited.

4. Research on Jinuo Medicine, published by Yunnan Publishing House in 2000, editor in chief.

5. Color Picture Book of Anticancer Drugs, published by People's Health Publishing House in 2000, editor in chief.

6. Common Chinese herbal medicine cultivation, published by Chinese Medicine Press 200 1, editor-in-chief.

7. Common medicinal plants, published by People's Health Publishing House 200 1, editor in chief.

8. Breeding and Processing Technology of Medicinal Animals and Plants, 200 1, edited by China Traditional Chinese Medicine Publishing House.

9. Newly edited Yearbook of Traditional Chinese Medicine, 2002, Chemical Industry Press, deputy editor.

10, Atlas of Primary Colors of Practical Chinese Herbal Medicine, 2002, edited by China Agricultural Publishing House, 1. Ex situ conservation and utilization of medicinal plant germplasm resources in China. Second prize of national scientific and technological progress. Xiao, Chen Shilin, Zhang Bengang, Wei Jianhe, Zhou Qingnian, Miao Jianhua, Zhang Zhao, Yang Shilin and Li.

2. Development and application of biphasic capsule preparation technology and multifunctional capsule filling machine. Second prize of scientific and technological progress in Jiangxi province. Luo, Yang Shilin, Jian Hui, Lu Aiping, Gong Jianping, Rao Yi. 2009.

3. Research and application of key techniques for breeding endangered medicinal material cistanche deserticola. The Science and Technology Award of Chinese Medicine Society won the third prize. Chen Jun, Liu, Yu Jing, Cheng, Huang Jianli, Xu Rong, Chen Shilin, Yang Shilin. 2006.

4. "The key technology of modern industrialization of traditional Chinese medicine tablets with large and irregular tablets as the core. First prize of scientific and technological progress in Jiangxi province. Liu Hongning, Yi, Liu Xuhai, Luo, Lu Jianzhong, Yang Shilin, Le Yuning,,, Gong Xiaoying. 20654.00000000005

5. Development and application of common and scarce chemical reference materials of traditional Chinese medicine. Third prize of scientific and technological progress in Jiangxi province. Yang Shilin, Wang Yuesheng, Jianhui, Feng Yulin, Rao Yi, Fan Meimei, He Mingzhen, Wu Huan, Zhang Xiaojuan, Xia Qian, Hou Li. 20 10. member Chinese People's Political Consultative Conference, executive vice president of China association for the promotion of traditional Chinese medicine, vice president of China GAP society, and vice president of China new medical doctor forum. Honorary chairman of Chinese Medicine Chemistry Committee of Chinese Medicine Association, member of National Pharmacopoeia Committee, member of National New Drug Evaluation Committee, scientific and technological consultant of Shandong provincial government, scientific and technological consultant of Qinghai provincial government, scientific and technological consultant of Sichuan provincial government, modernization consultant of Chinese medicine of Guizhou provincial government, editorial board of Phytotherapy Research, deputy editor of Chinese Herbal Medicine, and deputy editor of New Chinese Medicine and Clinical Pharmacology.